Botulinum Toxin Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Botulinum Toxin Market by Product Type (Botulinum Toxin A), Distribution Channel (Retail Pharmacies, Beauty Clinics, and Online Pharmacies) and Geography 

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Botulinum Toxin Market size was valued at USD 3.42 billion in 2021 and is poised to grow at a significant CAGR of 7.5% over 2022–2028. The global botulinum toxin market benefits from rapid growth in the cosmetics industry and increasing research and development. Botulinum toxin is commonly used to address wrinkles, frown lines, forehead lines, square jaws, crow’s feet, and other aging indications. Furthermore, an increase in the number of manufacturers and users in various economies will boost the market growth. As a result, the expanding influence of aesthetics among the population and the growing number of producers from multiple developed and emerging countries propels the botulinum toxin market worldwide. The remarkable efficacy of botulinum toxins in medicinal applications has boosted the botulinum toxin market tremendously. The increased awareness of botulinum toxin benefits in both developed and emerging countries will open many new business opportunities.  In recent years, emerging economies have started as competitive market players in the past few years. With the expanding influence of the fashion and aesthetics industries, botulinum toxin providers will have a lot of growth options in the coming years. For example, Allergan PLC, a global leader in botulinum toxin manufacture, launched a campaign called “See Yourself” in June 2021, which showcases the success stories of genuine Botox cosmetic patients. This campaign was launched as part of its global efforts to reach out to its target demographics and customers.

Recent Market Developments:

In Feb 2021, the United States Food and Drug Administration approved Allergan’s BOTOX (onabotulinumtoxinA) neurotoxin to treat pediatric detrusor overactivity associated with a neurologic condition.

In December 2020, Merz Therapeutics announced the U.S. FDA approval for its botulinum toxic product Xeomin to treat patients aged two years and older with chronic sialorrhea or drooling. With this approval, the company will be able to expand its customer base and increase its revenue stream.

Botulinum Toxin Market

MARKET SUMMARY
-
7.5%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 7.5%
  • Largest Market– North-America
  • Fastest Growing Market– Europe

Botulinum Toxin Market

  • The global botulinum toxin market report gives comprehensive outlook on Botulinum Toxin Market across the globe with special emphasis on key regions such as Asia Pacific, North America, Europe, Latin America, and Middle East and Africa.
  • The report on global botulinum toxin market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, distribution channel, and geography.
key players
  • Allergan PLC (Ireland)
  • Merz Pharma Gmbh (Germany)
  • Galderma (Nestle)
  • Medytoc Solutions Inc (U.S)
  • Ipsen (France)
Botulinum Toxin Market

DRIVERS AND RESTRAINTS

to meet the increasing demand for botulinum toxin. The botulinum toxin market is likely to rise as a result of this. While botulinum toxin is primarily utilized to treat cosmetic problems, its therapeutic application is significantly broader. Botulinum toxin is an effective treatment option for persistent migraines, muscle spasms, reagent bladder, and hyperhidrosis. For instance, in June 2019, Huon’s Global, a South Korean company, declared the unveiling of Liztox, a botulinum neurotoxin based in Korea, for the treatment of reasonable to prominent glabellar wrinkles. However, Mild pain, swelling, or bruising around the injection site, flu-like symptoms, a headache, an upset stomach, temporary eyelid drooping, numbness, lethargy, generally feeling poorly, and brief undesired weakness or paralysis in adjacent muscles are all possible adverse effects of high usage.


North-America got significant share

Botulinum Toxin Market

The botulinum toxin market in North America is likely to hold the highest revenue share in 2022, and in the following years, it is predicted to increase rapidly. Due to improved technology, patients seeking medical help now have access to various treatments and products. The United States has a high rate of botulinum toxin adoption, which will help the botulinum toxin market grow in North America. Europe has a significant share of the market. It is expected to grow in the coming years due to rising expenditure on research and development activities, inclination towards beauty consciousness and aesthetic surgeries, and the adoption of non-invasive or minimally invasive botulinum toxin procedures.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Findings of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2016-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Botulinum Toxin Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The botulinum toxin market is projected to expand at a CAGR of 7.5% during the forecast period

Allergan PLC (Ireland), Merz Pharma Gmbh (Germany), Galderma (Nestle), Medytoc Solutions Inc (U.S), Ipsen (France)

North America  is the fastest-growing region for botulinum toxin market


Report

Table Of Content

Table of Contents

  1. Executive summary
  2. Global Botulinum Toxin Market Introduction
    • Global Botulinum Toxin Market – Taxonomy
    • Global Botulinum Toxin Market –Definitions
      • By Product Type
      • By Distribution Channel
  1. Global Botulinum Toxin Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Botulinum Toxin Market Dynamics – Factors Impact Analysis
    • Number of Botulinum Toxin Procedures (2016)
    • Pipeline Products
    • New Product Launches
  2. Global Botulinum Toxin Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026
    • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Botulinum Toxin Market, By Product Type, 2015 – 2019 and Forecast, 2020 – 2026
    • Botulinum Toxin A
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Botulinum Toxin B
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  4. Global Botulinum Toxin Market Forecast, By Distribution Channel Type, 2015 – 2019 and Forecast, 2020 – 2026
    • Retail Pharmacies
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Beauty Clinics
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  5. Global Botulinum Toxin Market Analysis, By Region, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Botulinum Toxin Market – Opportunity Analysis Index, By Product Type, By End User, and Region, 2020 – 2026
  6. North America Botulinum Toxin Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026
    • By Product Type Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Botulinum Toxin A
      • Botulinum Toxin B
    • Distribution Channel Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Retail Pharmacies
      • Beauty Clinics
      • Others
    • Country Analysis 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US.
      • Canada
    • North America Botulinum Toxin Market – Opportunity Analysis Index, By Product Type, End User, and Country, 2020 – 2026
    • North America Botulinum Toxin Market Dynamics – Trends
  7. Europe Botulinum Toxin Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026
    • By Product Type Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Botulinum Toxin A
      • Botulinum Toxin B
    • Distribution Channel Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Retail Pharmacies
      • Beauty Clinics
      • Others
    • Country Analysis 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Rest of Europe
    • Europe Botulinum Toxin Market – Opportunity Analysis Index, By Product Type, End User, and Country, 2020 – 2026
    • Europe Botulinum Toxin Market Dynamics – Trends
  8. Asia-Pacific Botulinum Toxin Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026
    • By Product Type Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Botulinum Toxin A
      • Botulinum Toxin B
    • Distribution Channel Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Retail Pharmacies
      • Beauty Clinics
      • Others
    • Country Analysis 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Botulinum Toxin Market – Opportunity Analysis Index, By Product Type, End User, and Country, 2020 – 2026
    • Asia-Pacific Botulinum Toxin Market Dynamics – Trends
  9. Latin America Botulinum Toxin Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026
    • By Product Type Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Botulinum Toxin A
      • Botulinum Toxin B
    • Distribution Channel Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Retail Pharmacies
      • Beauty Clinics
      • Others
    • Country Analysis 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentian
      • Venezula
      • Rest of Latin America Brazil
    • Latin America Botulinum Toxin Market – Opportunity Analysis Index, By Product Type, End User, and Country, 2020 – 2026
    • Latin America Botulinum Toxin Market Dynamics – Trends
  10. Middle East and Africa Botulinum Toxin Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026
    • By Product Type Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Botulinum Toxin A
      • Botulinum Toxin B
    • Distribution Channel Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Retail Pharmacies
      • Beauty Clinics
      • Others
    • Country Analysis 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of Middle East and Africa
    • Middle East and Africa Botulinum Toxin Market – Opportunity Analysis Index, By Product Type, End User, and Country, 2020 – 2026
    • Middle East and Africa Botulinum Toxin Market Dynamics – Trends
  11. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Galderma (Nestle)
      • Merz Pharma GmbH & Co. KGaA
      • Allergan
  1. Research Methodology
  2. Key Assumptions and Acronyms

Report

Company Profile

  • AbbVie Inc.
  • Ipsen Pharma
  • Revance Therapeutics, Inc.
  • Merz Pharma
  • Medytox
  • USWM, LLC.
  • GALDERMA
  • Lanzhou Institute of Biological Products Co., Ltd.
  • HUGEL, Inc.
  • Allergan PLC

Description

Botulinum Toxin Market size was valued at USD 3.42 billion in 2021 and is poised to grow at a significant CAGR of 7.5% over 2022–2028. The global botulinum toxin market benefits from rapid growth in the cosmetics industry and increasing research and development. Botulinum toxin is commonly used to address wrinkles, frown lines, forehead lines, square jaws, crow’s feet, and other aging indications. Furthermore, an increase in the number of manufacturers and users in various economies will boost the market growth. As a result, the expanding influence of aesthetics among the population and the growing number of producers from multiple developed and emerging countries propels the botulinum toxin market worldwide. The remarkable efficacy of botulinum toxins in medicinal applications has boosted the botulinum toxin market tremendously. The increased awareness of botulinum toxin benefits in both developed and emerging countries will open many new business opportunities.  In recent years, emerging economies have started as competitive market players in the past few years. With the expanding influence of the fashion and aesthetics industries, botulinum toxin providers will have a lot of growth options in the coming years. For example, Allergan PLC, a global leader in botulinum toxin manufacture, launched a campaign called “See Yourself” in June 2021, which showcases the success stories of genuine Botox cosmetic patients. This campaign was launched as part of its global efforts to reach out to its target demographics and customers.

Recent Market Developments:

In Feb 2021, the United States Food and Drug Administration approved Allergan’s BOTOX (onabotulinumtoxinA) neurotoxin to treat pediatric detrusor overactivity associated with a neurologic condition.

In December 2020, Merz Therapeutics announced the U.S. FDA approval for its botulinum toxic product Xeomin to treat patients aged two years and older with chronic sialorrhea or drooling. With this approval, the company will be able to expand its customer base and increase its revenue stream.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX